CompletedNot Applicable

A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

United States498 participantsStarted 2010-01

Plain-language summary

A long term observational study in sickle cell disease will enhance the understanding of the disease patterns, current transfusion practices, treatments and outcomes in sickle cell disease.

Who can participate

Age range2 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female patients with HbSS, HbS/beta-thalassemia and HbSC * Age \> 2 years old. * Written informed consent by the patient or legal guardians, and pediatric assent where indicated. Exclusion Criteria: * Patients with Sickle Cell trait (HbAS) are not eligible for the study * Patient or legal guardians unable or unwilling to give consent, or pediatric assent where indicated.

What they're measuring

Document current treatment patterns, natural history and outcomes in patients with sickle cell disease

Timeframe: up to 5 years

Trial details

NCT IDNCT01220115

SponsorNovartis

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2014-09

View on ClinicalTrials.gov More Sickle Cell Disease trials